Key result
Heme exposure cuts maximal active force ~46% in human skeletal muscle fibres.
Why the study?
Heme released from red blood cells targets cell components including the cytoskeleton, but its impact on human skeletal muscle fibres was unknown.
Does free heme exposure lead to contractile dysfunction and protein oxidation in human skeletal muscle fibres?
Does free heme exposure lead to contractile dysfunction and protein oxidation in human skeletal muscle fibres?
Absolute Event Rate: 19.8% vs 36.4%
Free heme induces significant contractile dysfunction and protein oxidation in human skeletal muscle fibres, offering a potential molecular mechanism for muscle weakness in hemolytic diseases and chronic heart failure.
May contribute to muscle weakness in hemolytic diseases and HF; hypothesis-generating for heme-targeted interventions pending clinical trials.
Heme released from red blood cells targets a number of cell components including the cytoskeleton. The purpose of the present study was to determine the impact of free heme (20–300 µM) on human skeletal muscle fibres made available during orthopedic surgery. Isometric force production and oxidative protein modifications were monitored in permeabilized skeletal muscle fibre segments. A single heme exposure (20 µM) to muscle fibres decreased Ca2+-activated maximal (active) force (Fo) by about 50% and evoked an approximately 3-fold increase in Ca2+-independent (passive) force (Fpassive). Oxidation of sulfhydryl (SH) groups was detected in structural proteins (e.g., nebulin, α-actinin, meromyosin 2) and in contractile proteins (e.g., myosin heavy chain and myosin-binding protein C) as well as in titin in the presence of 300 µM heme. This SH oxidation was not reversed by dithiothreitol (50 mM). Sulfenic acid (SOH) formation was also detected in the structural proteins (nebulin, α-actinin, meromyosin). Heme effects on SH oxidation and SOH formation were prevented by hemopexin (Hpx) and α1-microglobulin (A1M). These data suggest that free heme has a significant impact on human skeletal muscle fibres, whereby oxidative alterations in structural and contractile proteins limit contractile function. This may explain and or contribute to the weakness and increase of skeletal muscle stiffness in chronic heart failure, rhabdomyolysis, and other hemolytic diseases. Therefore, therapeutic use of Hpx and A1M supplementation might be effective in preventing heme-induced skeletal muscle alterations.
No takes yet. Share an insight, caveat, or question.
Alvarado et al. (2020) studied Healthy muscle tissue (obtained during orthopedic surgery) (n=3). Free heme vs. Vehicle (NaOH) / Baseline before exposure was evaluated on Ca2+-activated maximal (active) force (Fo). A single 20 µM heme exposure decreased Ca2+-activated maximal active force by about 50% and evoked an approximately 3-fold increase in Ca2+-independent passive force in human skeletal muscle fibres.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: